39 results
Page 2 of 2
S-4
8zc50ryvbhh56
23 Jun 20
Registration of securities issued in business combination transactions
12:28pm
S-4
EX-10.38
c0jq5zuu1j n1mj3zmq
23 Jun 20
Registration of securities issued in business combination transactions
12:28pm
8-K
EX-2.1
bt8mn
29 Apr 20
Entry into a Material Definitive Agreement
8:33am
425
EX-2.1
6z330pv
29 Apr 20
Business combination disclosure
8:32am
8-K
EX-99.1
agtko
12 Mar 20
Results of Operations and Financial Condition
8:00am
8-K
EX-99.1
er4rbwy3o65
19 Feb 20
Regulation FD Disclosure
8:06am
8-K
EX-99.2
72hswuz4aafyoly jk
19 Feb 20
Regulation FD Disclosure
8:06am
8-K
EX-99.1
82g9zmso
3 Dec 19
Regulation FD Disclosure
7:31am
8-K
EX-99.1
x6ka03 yzhal0
18 Nov 19
Regulation FD Disclosure
7:30am
8-K
EX-99.1
yl98eal z2
15 Nov 19
Other Events
7:31am
8-K
EX-1.1
t22zh2qwaqaoioi8toh0
20 Mar 19
Public Offering of Common Stock
9:42pm
8-K
EX-99.1
gjkf 1u9794mefy
18 Mar 19
Positive End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA); Phase 3 program of RTB101 expected to initiate in 2Q19
4:02pm
8-K
EX-99.2
awizn51ovu8p8u7etv
7 Feb 19
Regulation FD Disclosure
8:01am
S-3
EX-1.2
ddm8gdw5oi ba5nu31k7
1 Feb 19
Shelf registration
5:31pm
8-K
EX-99.1
h0xyjio1n1aj rf
13 Nov 18
Initiation of pivotal Phase 3 program of RTB101 in RTIs expected in 1H19
8:10am
10-K
kuw2gk 5b8mfbqkj3
29 Mar 18
Annual report
12:00am